Plasminogen activator inhibitor in plasma is related to testosterone in men.

[1]  J. Jespersen,et al.  On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarction. , 2009, Acta medica Scandinavica.

[2]  B. Alving,et al.  Plasminogen activator and plasminogen activator inhibitor activities in a reference population. , 1988, American journal of clinical pathology.

[3]  E. Kruithof,et al.  Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation. , 1987, Blood.

[4]  J. Sampol,et al.  Release Pattern of the Vascular Plasminogen Activator and Its Inbibitor in Human Postvenous Occlusion Plasma as Assessed by a Spectrophotometric Solid-Phase Fibrin-tPA Activity Assay , 1987, Thrombosis and Haemostasis.

[5]  M. Blombäck,et al.  PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION , 1987, The Lancet.

[6]  M. Alessi,et al.  Metformin Decreases the High Plasminogen Activator Inhibition Capacity, Plasma Insulin and Triglyceride Levels in Non-Diabetic Obese Subjects , 1987, Thrombosis and Haemostasis.

[7]  M. Alessi,et al.  Deficient t-PA Release and Elevated PA Inhibitor Levels in Patients with Spontaneous or Recurrent Deep Venous Thrombosis , 1987, Thrombosis and Haemostasis.

[8]  C. Kluft,et al.  Plasminogen activator inhibitors. , 1987, Blood.

[9]  S. Thompson,et al.  HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.

[10]  R. Desai,et al.  Sex Hormone Levels in Young Indian Patients with Myocardial Infraction , 1986, Arteriosclerosis.

[11]  J. Jespersen,et al.  Inhibition of Tissue-Type Plasminogen Activator in Plasma of Women Using Oral Contraceptives and in Normal Women During a Menstrual Cycle , 1986, Thrombosis and Haemostasis.

[12]  M. Alessi,et al.  Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. , 1986, Metabolism: clinical and experimental.

[13]  M. Blombäck,et al.  Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. , 1985, The New England journal of medicine.

[14]  F. Werf,et al.  Plasminogen activator inhibitor in the blood of patients with coronary artery disease. , 1985, British medical journal.

[15]  M. Herold,et al.  ESSENTIAL ROLE OF POST-HEPARIN LIPOPROTEIN LIPASE ACTIVITY AND OF PLASMA TESTOSTERONE IN CORONARY ARTERY DISEASE , 1985, The Lancet.

[16]  M. Blombäck,et al.  The role of the fibrinolytic system in deep vein thrombosis. , 1985, The Journal of laboratory and clinical medicine.

[17]  J. Verheijen,et al.  Modulation of Rapid Plasminogen Activator Inhibitor in Plasma by Stanozolol , 1984, Thrombosis and Haemostasis.

[18]  M. Wheeler,et al.  Relationship of high density lipoprotein cholesterol with total and free testosterone and sex hormone binding globulin. , 1983, Acta endocrinologica.

[19]  P. Hugenholtz,et al.  Post-heparin lipases, lipids and related hormones in men undergoing coronary arteriography to assess atherosclerosis. , 1983, Atherosclerosis.

[20]  B. Wiman,et al.  Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. , 1983, Thrombosis research.

[21]  M. Vitiello,et al.  Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. , 1983, The Journal of clinical endocrinology and metabolism.

[22]  W. Castelli,et al.  Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort. , 1983, The American journal of medicine.

[23]  J. Hickman,et al.  Abnormal Hormone Levels in Men with Coronary Artery Disease , 1982, Arteriosclerosis.

[24]  J. Deslypere,et al.  Androgens, oestrogens, and coronary heart disease. , 1981, British medical journal.

[25]  A. Nordøy,et al.  Sex hormones and high density lipoproteins in healthy males. , 1979, Atherosclerosis.

[26]  A. Kenmure,et al.  RAISED PLASMA ŒSTRADIOL AND ŒSTRONE LEVELS IN YOUNG SURVIVORS OF MYOCARDIAL INFARCTION , 1978, The Lancet.

[27]  G. Phillips.  EVIDENCE FOR HYPERŒSTROGENÆMIA AS A RISK FACTOR FOR MYOCARDIAL INFARCTION IN MEN , 1976, The Lancet.

[28]  Cox Bs.  Letter: Elective induction of labour. , 1975 .

[29]  Oxon Dm.  Obituary. Rupert Samuel Bruce Pearson. , 1974 .

[30]  R. Chakrabarti,et al.  Increase of blood fibrinolytic activity by testosterone. , 1962, Lancet.

[31]  Attwater Hl.  Surgery of urethral stricture. , 1948 .

[32]  C. Rimington,et al.  Folic acid in megaloblastic anemia after total gastrectomy; report of a case. , 1947, Lancet.

[33]  P. Caron,et al.  Plasma fibrinolytic activity in a group of hypogonadic men. , 1987, Scandinavian journal of clinical and laboratory investigation.

[34]  C. Kluft.  Occurrence of C1 inactivator and other proteinase inhibitors in euglobulin fractions and their influence on fibrinolytic activity. , 1976, Haemostasis.

[35]  O. Winther.  Testosterone and fibrinolytic activity. , 1967, Scandinavian journal of clinical and laboratory investigation. Supplementum.